6842 studies found for:    "Growth Substances"
Show Display Options
Download search resultsDownload the search results for:
"Growth Substances" (6842 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Conditions: Metastatic Hepatocellular Carcinoma;   Advanced Liver Cancer
Interventions: Drug: Ascorbic Acid + Sorafenib;   Drug: Sorafenib alone
2 Active, not recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
3 Terminated Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Condition: Stage IV Colorectal Cancer
Intervention: Drug: Vitamin C
4 Terminated Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Pancreatic Neoplasms;   Advanced Disease;   Sunitinib
Intervention: Drug: Sutent
5 Terminated Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
Conditions: Hepatocellular Carcinoma;   Fibrolamellar Hepatocellular Carcinoma
Intervention: Drug: Sutent
6 Completed Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)
Conditions: Respiratory Tract Infections;   Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil);   Dietary Supplement: Miglyol oil
7 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
8 Completed Patellar Tendon Regeneration With Platelet-rich Plasma
Condition: Knee Instability
Interventions: Procedure: Platelet-rich plasma;   Procedure: Control group
9 Terminated Growth Hormone and Heart Failure
Condition: Heart Failure, Congestive
10 Completed A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
Conditions: HIV Infections;   Peripheral Nervous System Disease
Intervention: Drug: Nerve Growth Factor, Recombinant Human
11 Not yet recruiting Physiologic Interactions Between the Adrenal- and the Parathyroid Glands
Conditions: Secondary Hyp;   Vitamin D Deficiency
Interventions: Drug: Valsartan;   Drug: Placebo Valsartan;   Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo cholecalciferol
12 Completed Dorzolamide-timolol Eye Drops Given With Eye Injections to Treat Age-related Macular Degeneration
Conditions: Wet Macular Degeneration;   Age-related Macular Degeneration
Intervention: Drug: Dorzolamide-timolol
13 Not yet recruiting Effectiveness of Vitamin D on the Clinical Management of Pediatric Patients With Asthma
Condition: Asthma
Intervention: Drug: Vitamin D3
14 Recruiting Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy
Condition: Clear-cell Metastatic Renal Cell Carcinoma
Intervention: Drug: patients with sunitinib or pazopanib
15 Not yet recruiting HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
Condition: Recurrent Plasma Cell Myeloma
Interventions: Drug: Dexamethasone;   Drug: HDAC Inhibitor AR-42;   Other: Laboratory Biomarker Analysis;   Drug: Pomalidomide
16 Not yet recruiting Lenalidomide and Blinatumomab in Treating Patients With Relapsed Non-Hodgkin Lymphoma
Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma;   Mediastinal Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Burkitt Lymphoma;   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Small Lymphocytic Lymphoma
Interventions: Biological: Blinatumomab;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide
17 Not yet recruiting Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
Condition: Metastatic Colorectal Cancer
Interventions: Biological: Sym004;   Drug: Irinotecan;   Drug: Folinic Acid;   Drug: Fluorouracil
18 Recruiting Comparison of Two Nutrition Interventions in Young Children in El Salvador
Condition: Micronutrient Deficiency
Interventions: Dietary Supplement: 21 micronutrient-fortified supplement;   Dietary Supplement: Cereal Fortificado (Fortified Cereal);   Dietary Supplement: Ferrous sulphate;   Dietary Supplement: Vitamin A
19 Not yet recruiting Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Rifapentine;   Drug: Moxifloxacin;   Drug: Rifampin;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Ethambutol;   Dietary Supplement: Pyridoxine
20 Not yet recruiting Can Correction of Low Vitamin D Status in Infancy Program for a Leaner Body Composition?
Conditions: Healthy;   Vitamin D Deficiency
Intervention: Dietary Supplement: cholecalciferol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years